Navigation Links
'Non-invasive' cultivar? Buyer beware
Date:10/6/2011

Cultivars of popular ornamental woody plants that are being sold in the United States as non-invasive are probably anything but, according to an analysis by botanical researchers published in the October issue of BioScience. Tiffany M. Knight of Washington University in St. Louis, Missouri, and her coauthors at the Chicago Botanic Garden write that the claims of environmental safety are in most cases based on misleading demographic evidence that greatly underestimates the plants' invasive potential. What is more, the offspring of cultivars do not usually "breed true" and may be more fecund than their parents, especially if they cross with plants from nearby feral populations.

Many invasive plants were once ornamental cultivars, because the characteristics that the "green" industry looks for are the same ones that make a plant potentially invasive -- being adaptable to wide range of conditions, forming dense stands good for erosion control, and having a long flowering period, for example. In recent years the nursery and horticultural industries have responded by creating cultivars of top-selling plants that produce reduced numbers of viable seed and are advertized as "safe to natural areas." Such cultivars of Japanese barberry, buckthorn, and burning bush are now widely sold, as they avoid bans on growing invasive species.

Yet simple population modeling demonstrates that reductions of even 95 percent in the number of viable seed will leave a long-lived species quite capable of spreading -- and many of the new cultivars do not achieve even that much of a reduction. More sophisticated modeling would likely reveal even stronger invasive potential of the "safe" cultivars. Knight and her co-authors conclude that only completely sterile cultivars can be considered truly safe without further testing, and that other types should be tested for breeding true and having a low growth rate before they are sold as non-invasive.


'/>"/>
Contact: Tim Beardsley
tbeardsley@aibs.org
703-654-2500 x326
American Institute of Biological Sciences
Source:Eurekalert

Page: 1

Related biology news :

1. Potential for non-invasive brain tumor treatment
2. Buyer beware: Dangerous levels of lead found in used consumer products
3. Amphibians: Beware young beetles deadly siren call
4. Beware of predatory male black bears
5. Coffee, energy drinkers beware: Many mega-sized drinks loaded with sugar, MU nutrition expert says
6. Urban gardeners beware: There may be lead in your soil and food
7. NASA scientist publishes new book: Coming Climate Crisis? Consider the Past, Beware the Big Fix
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... Minn. , Jan. 18, 2017 ... technology company that supports the entire spectrum of ... has been another record-breaking year for the organization ... market interest in MedNet,s eClinical products and services. ... the tremendous marketplace success of iMedNet ...
(Date:1/12/2017)... and PUNE, India , January 12, 2017 ... and Forecasts, 2015 - 2022," projects that the global biometric technology market is expected ... from 2016 to 2022. Continue Reading ... ... ...
(Date:1/6/2017)... , Jan. 5, 2017  SomaLogic announced today ... Life Alliance" established by iCarbonX, the ... build a "Global Digital Health Ecosystem that can ... combination of individual,s biological, behavioral and psychological data, ... between the companies, SomaLogic will provide proteomics data ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... , Jan. 19, 2017 /PRNewswire -- WuXi AppTec, ... open-access capability and technology platform, today announced that ... biology focused preclinical drug discovery contract research organization ... become a wholly-owned subsidiary of WuXi, and will ... and providing greater services. The acquisition will further ...
(Date:1/19/2017)... and GAITHERSBURG, Md. , Jan. ... and Altimmune, Inc., a privately-held immunotherapeutics company targeting ... definitive agreement for the merger of PharmAthene and ... include Novartis Venture Fund, HealthCap, Truffle Capital and ... fully-integrated and diversified immunotherapeutics company with four clinical ...
(Date:1/19/2017)... Ca (PRWEB) , ... January 18, 2017 , ... ... events for tech innovators, engineers, and scientists from around the world, was today ... News. The awards program is based entirely on merit and decided upon by ...
(Date:1/19/2017)... BETHESDA, Md. , Jan. 18, 2017  Northwest ... company developing DCVax® personalized immune therapies for operable and ... Marnix Bosch , Chief Technical Officer of NW Bio, ... Thursday, January 19, 2017, at the Hyatt Regency Hotel ... Dr. Bosch will chair the session entitled "New Therapeutic ...
Breaking Biology Technology: